Table 3.
Stage definition (BCLC 2018 update) | Estimated survival | |
Stage 0—Very early-stage | Single nodule ≤2 cm; ECOG PS 0*; Preserved liver function |
>5 years |
Stage A—Early-stage | Single or up to three nodules ≤3 cm; ECOG PS 0*; Preserved liver function |
>5 years |
Stage B—Intermediate-stage | Multinodular; ECOG PS 0*; Preserved liver function |
>2 to 5 years |
Stage C—Advanced-stage | Portal invasion; Extrahepatic spread; ECOG PS 1–2; Preserved liver function |
>1 year |
Stage D—Terminal-stage | ECOG PS 3–4; End-stage liver function |
3 months |
*The American Association for the Study of Liver Disease (AASLD) recommends including ECOG PS 0 to 1 in stage 0, A and B, because of the significant overlap between PS 0 and PS 1
BCLC, Barcelona-Clinic Liver Cancer; ECOG, Eastern Cooperative Oncology Group; PS, performance status.